Sorrento Therapeutics SRNE
$ 0.27
-29.58%
Quarterly report 2023-Q1
added 05-15-2023
Country |
USA |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Henry Ji |
Employees in the company |
310 |
Shares |
295 M |
Market Cap[1] |
$ 126 M |
EBITDA (LTM) |
$ -418 M |
P/E (LTM) |
-0.24 |
P/S (LTM) |
3.62 |
EPS (LTM) |
-1.12 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.